Literature DB >> 20164779

Noninvasive diagnosis and prognosis of liver cirrhosis: a comparison of biological scores, elastometry, and metabolic liver function tests.

Julien Forestier1, Jérôme Dumortier, Olivier Guillaud, Marie Ecochard, Sabine Roman, Olivier Boillot, Delphine Lutringer, Jean-Yves Scoazec, Fabien Subtil, François Mion.   

Abstract

BACKGROUND: Recently, noninvasive methods for the diagnosis of liver cirrhosis have been extensively developed. We assessed the accuracy of liver stiffness measurement, aspartate aminotransferase-to-platelet ratio index (APRI) score, 13C-aminopyrine breath test, and indocyanine green plasma clearance for the diagnosis of cirrhosis in patients with chronic liver disease and for the prediction of severe complications in cirrhotic patients.
METHODS: A total of 296 consecutive patients with chronic liver diseases of various causes were studied. Diagnostic accuracy was assessed by receiver operating characteristic curve analysis.
RESULTS: Areas under the receiver operating characteristic curve for the diagnosis of cirrhosis were (95% confidence interval) 0.93 (0.90-0.96) for liver stiffness measurement, 0.82 (0.77-0.87) for 13C-aminopyrine breath test, and 0.81 (0.76-0.86) for APRI score. Using cutoff values of 14.1 kPa for liver stiffness, 4.15% dose/h for 13C-aminopyrine breath test, and 1 for APRI score, the positive predictive value was approximately 90% for the diagnosis of cirrhosis. Using cutoff values of 65.2 kPa for liver stiffness, 1.17% dose/h for 13C-aminopyrine breath test, 2.82 for APRI score, and 51.1% for indocyanine green plasma clearance, the positive predictive value was approximately 80% for the occurrence of severe complications among cirrhotic patients.
CONCLUSION: Liver stiffness measurement, 13C-aminopyrine breath test, indocyanine green plasma clearance, and APRI score are reliable noninvasive methods for the diagnosis of cirrhosis in patients with chronic liver diseases of various causes, and are also prognostic indicators for the occurrence of severe complications in cirrhotic patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20164779     DOI: 10.1097/MEG.0b013e3283343f58

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  15 in total

1.  Correlation of aspartate aminotransferase/platelet ratio index with hepatic venous pressure gradient in cirrhosis.

Authors:  Vipin Verma; Shiv Kumar Sarin; Praveen Sharma; Ashish Kumar
Journal:  United European Gastroenterol J       Date:  2014-06       Impact factor: 4.623

Review 2.  Liver stiffness is associated with risk of decompensation, liver cancer, and death in patients with chronic liver diseases: a systematic review and meta-analysis.

Authors:  Siddharth Singh; Larissa L Fujii; Mohammad Hassan Murad; Zhen Wang; Sumeet K Asrani; Richard L Ehman; Patrick S Kamath; Jayant A Talwalkar
Journal:  Clin Gastroenterol Hepatol       Date:  2013-08-15       Impact factor: 11.382

Review 3.  Molecular prognostic prediction in liver cirrhosis.

Authors:  Nicolas Goossens; Shigeki Nakagawa; Yujin Hoshida
Journal:  World J Gastroenterol       Date:  2015-09-28       Impact factor: 5.742

Review 4.  Noninvasive assessment of liver function.

Authors:  Steve Helmke; Jordi Colmenero; Gregory T Everson
Journal:  Curr Opin Gastroenterol       Date:  2015-05       Impact factor: 3.287

5.  Soluble CD163 for Prediction of High-Risk Esophageal Varices and Variceal Hemorrhage in Patients with Liver Cirrhosis.

Authors:  Mohamed Yousri Taher; Abeer El-Hadidi; Assem El-Shendidi; Ahmed Sedky
Journal:  GE Port J Gastroenterol       Date:  2021-07-27

6.  Characteristics of Liver Disease in 100 Individuals With Joubert Syndrome Prospectively Evaluated at a Single Center.

Authors:  Anna Strongin; Theo Heller; Dan Doherty; Ian A Glass; Melissa A Parisi; Joy Bryant; Peter Choyke; Baris Turkbey; Kailash Daryanani; Deniz Yildirimli; Meghana Vemulapalli; Jim C Mullikin; May C Malicdan; Thierry Vilboux; William A Gahl; Meral Gunay-Aygun
Journal:  J Pediatr Gastroenterol Nutr       Date:  2018-03       Impact factor: 2.839

7.  Enzymatic liver function capacity correlates with disease severity of patients with liver cirrhosis: a study with the LiMAx test.

Authors:  Maciej Malinowski; Maximilian Jara; Katja Lüttgert; James Orr; Johan Friso Lock; Eckart Schott; Martin Stockmann
Journal:  Dig Dis Sci       Date:  2014-07-04       Impact factor: 3.199

8.  Precise evaluation of liver histology by computerized morphometry shows that steatosis influences liver stiffness measured by transient elastography in chronic hepatitis C.

Authors:  Jérôme Boursier; Victor de Ledinghen; Nathalie Sturm; Laïla Amrani; Yannick Bacq; Jérémy Sandrini; Brigitte Le Bail; Julien Chaigneau; Jean-Pierre Zarski; Yves Gallois; Vincent Leroy; Zaytouna Al Hamany; Frédéric Oberti; Isabelle Fouchard-Hubert; Nina Dib; Sandrine Bertrais; Marie-Christine Rousselet; Paul Calès
Journal:  J Gastroenterol       Date:  2013-05-17       Impact factor: 7.527

9.  Evaluation of Aspartate Aminotransferase-to-Platelet Ratio Index as a Non-Invasive Marker for Liver Cirrhosis.

Authors:  Princi Jain; B K Tripathi; B Gupta; Bharti Bhandari; Divesh Jalan
Journal:  J Clin Diagn Res       Date:  2015-11-01

10.  Developing a 'traffic light' test with potential for rational early diagnosis of liver fibrosis and cirrhosis in the community.

Authors:  Nick Sheron; Mike Moore; Stacey Ansett; Camille Parsons; Adrian Bateman
Journal:  Br J Gen Pract       Date:  2012-09       Impact factor: 5.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.